PHVS
Pharvaris N.V.
NASDAQ · NLHealthcareBiotechnology
$33.55-3.98%
Price as of Jul 20, 2026
PHVS valuation
Pharvaris N.V. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 47.40x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.60x
- Price / sales
- —
- Price / cash flow
- -13.72x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- —
- EV / EBITDA
- -10.72x
- EV / EBIT
- -10.35x
- Market cap
- $2.3B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.